Theranos built a business around diagnostic tests that used only a few drops of blood. Business was good: the company was once valued at more than nine billion dollars. But in April 2016, Theranos announced that it was being investigated by criminal authorities and the Securities and Exchange Commission.
This is the story of Theranos, its CEO, and the legal background for these investigations. Billions of dollars, blood, and mythical beasts. All are featured in this commentary by University of Illinois Professor of Law Verity Winship.